Pluristem Therapeutics Enters into Cell Thawing Device License Agreement with Chart Industries, Inc.
HAIFA, Israel, Dec. 04, 2018 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel […]